XTL Biopharmaceuticals Ltd. (XTLB)
Nasdaq: XTLB · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2004
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts.The Form 20-F filed Jun 30, 2026 for the period ended Dec 31, 2025 is not in EDGAR's company facts yet; its figures here are that filing's own, read from the SEC's financial statement data sets.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Report filed | Jun 30, 2026 | Apr 30, 2025 | Apr 30, 2024 | Mar 22, 2023 | Mar 30, 2022 | Mar 15, 2021 | Mar 12, 2020 | Mar 11, 2019 | Mar 15, 2018 | Mar 30, 2017 |
| Revenue | · | 451 | · | · | · | · | · | · | · | · |
| Cost of revenue | · | 448 | · | · | · | · | · | · | · | · |
| Gross profit | · | 3 | · | · | · | · | · | · | · | · |
| Research and development | 28 | 16r | 31 | 30 | 30 | 38 | 35 | 38 | 43 | 443 |
| Sales and marketing | · | 487 | · | · | · | · | · | · | · | · |
| General and administrative | 1,437 | 759r | 734 | 850 | 1,001 | 910 | 807 | 755 | 1,203 | 1,270 |
| Operating income | -1,688 | -775r | -765 | -880 | -1,031 | -948 | -842 | -793 | -1,246 | -2,561 |
| Finance costs | 7 | 28 | · | 1,558 | 21 | 2,189r | 603 | 35 | 337 | 7 |
| Interest income | 60 | 34 | 41 | 36 | 1,487 | 183 | 682r | 3,814 | 802 | 23 |
| Net finance income (costs) | 929 | 1,015 | -1,017 | -468 | 1,466 | -2,006r | 79r | 4,423r | 465 | 16 |
| Income before income taxes | -759 | 240r | -1,782 | -1,348 | · | · | · | · | · | · |
| Income tax expense | · | -130 | · | · | · | · | · | · | · | · |
| Income from continuing operations | -759 | 240 | -1,782 | · | · | · | · | · | -781 | -2,545 |
| Income from discontinued operations | -6,210 | -1,267 | · | · | · | · | · | · | · | · |
| Net income | -6,969 | -1,027 | -1,782 | -1,348 | 435 | -2,954r | -763r | 3,630r | -781 | -2,545 |
| Net income to non-controlling interests | · | · | · | · | · | · | -1,347 | 2,986 | -781 | -2,545 |
| Earnings per share, basic | -0.008 | -0.002 | -0.003 | -0.002 | 0.001 | -0.006 | -0.001 | · | · | · |
| Earnings per share, diluted | -0.008 | -0.002r | -0.003 | -0.002 | 0.00 | -0.006 | -0.001 | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | · | -0.002 | -0.003 | 0.006 | -0.002 | -0.009 |
| Weighted average shares, basic | 896,174,328 | 673,044,737 | 544,906,149 | 544,906,149 | 531,995,467 | 514,205,799 | 514,205,799 | 514,205,799 | 470,188,629 | 274,035,533 |
| Weighted average shares, diluted | 896,174,328 | 673,044,737r | 544,906,149 | 544,909,149 | 615,548,446 | 514,205,799 | 514,205,799 | · | · | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
ifrs-full:RevenueCost of revenue what it cost to make or buy what it sold
ifrs-full:CostOfSalesGross profit revenue less the cost of what it sold
ifrs-full:GrossProfitResearch and development spent on inventing what it sells next
ifrs-full:ResearchAndDevelopmentExpenseSales and marketing the cost of finding and serving customers
ifrs-full:SalesAndMarketingExpenseGeneral and administrative the cost of running the company itself
ifrs-full:GeneralAndAdministrativeExpenseOperating income profit from running the business, before interest and tax
ifrs-full:ProfitLossFromOperatingActivitiesFinance costs what its borrowing cost
ifrs-full:InterestExpense
ifrs-full:FinanceCostsInterest income what its cash and investments earned
ifrs-full:RevenueFromInterest
ifrs-full:FinanceIncomeNet finance income (costs) interest earned less interest paid, outside the business
ifrs-full:FinanceIncomeCostIncome before income taxes profit before tax
ifrs-full:ProfitLossBeforeTaxIncome tax expense tax charged on the period's profit
ifrs-full:IncomeTaxExpenseContinuingOperationsIncome from continuing operations profit from the businesses it keeps
ifrs-full:ProfitLossFromContinuingOperationsIncome from discontinued operations profit or loss from businesses it sold or closed
ifrs-full:ProfitLossFromDiscontinuedOperationsNet income the whole group's profit, minority holders' share included
ifrs-full:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
ifrs-full:ProfitLossAttributableToNoncontrollingInterestsEarnings per share, basic net income per share outstanding
ifrs-full:BasicEarningsLossPerShareEarnings per share, diluted net income per share, counting every share that could be issued
ifrs-full:DilutedEarningsLossPerShareEarnings per share, basic and diluted net income per share, where both counts are the same
ifrs-full:BasicAndDilutedEarningsLossPerShareWeighted average shares, basic the average count of shares outstanding
ifrs-full:WeightedAverageSharesWeighted average shares, diluted the average count with every share that could be issued
ifrs-full:AdjustedWeightedAverageShares